Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Evolving business
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by QContinuum10on Jan 10, 2025 11:41am
22 Views
Post# 36398117

RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business

RE:RE:RE:RE:RE:RE:RE:RE:RE:Evolving business
Clongobongo wrote:
Here's the thing though, medipharm has 4 of the 36 approvals, and 9 of those approvals are verdemed/ eurofarma.

BUT, Verdemed states their products are manufactured in Canada and, it looks like they have not managed to import their products yet into the brazilian market, at least not on a significant scale. If you try to find Verdemed most recent approved products other than 50mg/ml or 25mg/ml are not found. I haven't found any products for eurofarma.

So in essence, you're looking at LABS owning 4 out of 29 approvals or less given maybe other manufacturers are having trouble getting those products to brazil.

Also medipharm potentially has more products currently undergoing approval, I would'nt be surprised they also have 50 and 25mg/ml in the pipeline for Teuto.


A bunch of assumptions in there I think but the general sentiment remains, let's hope Teuto can drive some business.

Researching what Teuto has in the review pipeline is a legitimate bear.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities